This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
from the US National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) to develop a prophylactic intranasal vaccine against Neisseria gonorrhoeae (NG). Additionally, antibiotic resistance is very prevalent for the NG bacterium. Intravacc has received a contract worth $14.6m
Researchers have produced vaccine-like immune responses to a dangerous bacterium by colonizing 26 healthy volunteers with a related, but harmless, commensal bacterial species.
A new clinical study has shown that supplements of a lactic acid bacterium may have positive effects by increasing the diversity of intestinal bacteria in these infants. Extremely preterm infants can suffer from a life-threatening inflammation of the gut.
Related: Red Meat Allergy Test Gets FDA Clearance. “We DNA vaccines designed using the platform consist of a combination of an advanced gene expression plasmid (pDNA) with gene(s) of interest, and a probiotic bacterium to deliver the vaccine directly to the gut, where it binds to intestinal epithelial cells.
However, IBS patients do not have allergies to any given foods, nor any gastrointestinal conditions, such as celiac disease. Moreover, the response did not induce symptoms typical of a food allergy. Approximately 20 percent of people in the world experience some form of pain or discomfort after a meal.
Undeclared Allergens in Snack Foods — The UK In the UK, several snack foods were recalled due to the presence of undeclared allergens , posing serious risks to individuals with allergies. This highlighted the need for more stringent labeling laws. In Utah, the Salt Lake County Health Department has reported 14 cases of infection.
It also has a significant presence in consumer health sectors such as dermatology, nutritionals and allergy. It is a macrolide lactone that was discovered in the fermentation broth of a Japanese soil sample that contained the bacterium Streptomyces tsukubensis. Global sales of Prograf totalled 198.8 billion JPY ($1.51
However, regulators are warning people with allergies to polyethylene glycol (PEG), an excipient in Pfizer’s vaccine, not to get vaccinated just yet. Vaccine Considerations. The vaccine has no safety concerns, nor have any serious adverse events related to the immunization been reported thus far.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content